Kolexia
Lebargy Francois
Pneumologie
Maison Blanche
Reims, France
134 Activités
2 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Fibrose pulmonaire Fibrose pulmonaire idiopathique Maladies pulmonaires Dyspnée Broncho-pneumopathie chronique obstructive Mucoviscidose Tumeurs du poumon Pneumopathie infectieuse

Industries

Boehringer Ingelheim
10 collaboration(s)
Dernière en 2023
Sanofi
3 collaboration(s)
Dernière en 2023
MSD
2 collaboration(s)
Dernière en 2022
RE-IMAGINE Health Agency
2 collaboration(s)
Dernière en 2021

Dernières activités

TETON-2: A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
Essai Clinique (United Therapeutics)   14 mars 2024
Bronchiectasis in renal transplant patients: a cross-sectional study.
European journal of medical research   13 février 2024
EXAFIP2: Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Randomized Controlled Trial
Essai Clinique (Centre Hospitalier Saint Joseph Saint Luc)   14 décembre 2023
Current cough and sputum assessed by the cough and sputum assessment-questionnaire (CASA-Q) is associated with quality of life impairment in cystic fibrosis.
BMC pulmonary medicine   21 novembre 2023
RINNOPARI: Cohort for Research and Innovation in Chronic Inflammatory Respiratory Diseases: The RINNOPARI Project
Essai Clinique (CHU Reims)   06 octobre 2023
Medicolegal litigation in cases of occupational lung disease: Some practical tips.
Revue des maladies respiratoires   17 mai 2023
Clinical relevance of low bone density in cystic fibrosis adult patients: A pilot study.
Medicine   10 janvier 2023
Tracheobronchopathia osteochondroplastica: clinical, bronchoscopic, and comorbid features in a case series.
BMC pulmonary medicine   17 novembre 2022
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
The Lancet. Oncology   11 août 2022
Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up: Multicentric Randomized Phase III Study of Post-Surgical NSCLC Follow-up
Essai Clinique (Intergroupe Francophone de Cancérologie Thoracique)   09 août 2022